|
|
以下节选自原文：Prostate cancer (PC) with high incidence (>1.1 million new cases each year) and
mortality (~300,000 deaths per year) presents a significant global public health burden [1,2].
Established risk factors of PC are age, race and family history of disease [3,4]. Although,
many risk factors are non-modifiable, association with preventable high fat diets, risk of PC
and progression of the disease have been observed in different studies [5–9].
1. Krušlin, B.; Škara, L.; Vodopi´c, T.; Vrhovec, B.; Murgi´c, J.; Štimac, G.; Fröbe, A.; Lež, C.; Ulamec, M.; Gall-Trošelj, K. Genetics of
Prostate Carcinoma. Acta Med. Acad. 2021, 50, 71–87. [CrossRef] [PubMed]
2. Abramovic, I.; Vrhovec, B.; Skara, L.; Vrtaric, A.; Gabaj, N.N.; Kulis, T.; Stimac, G.; Ljiljak, D.; Ruzic, B.; Kastelan, Z.; et al.
MiR-182-5p and miR-375-3p Have Higher Performance Than PSA in Discriminating Prostate Cancer from Benign Prostate
Hyperplasia. Cancers 2021, 13, 2068. [CrossRef]
3. Culp, M.B.; Soerjomataram, I.; Efstathiou, J.A.; Bray, F.; Jemal, A. Recent Global Patterns in Prostate Cancer Incidence and Mortality
Rates. Eur. Urol. 2020, 77, 38–52. Available online: http://www.sciencedirect.com/science/article/pii/S0302283819306190
(accessed on 5 September 2021). [CrossRef]
4. Adamaki, M.; Zoumpourlis, V. Immunotherapy as a Precision Medicine Tool for the Treatment of Prostate Cancer. Cancers 2021,
13, 173. [CrossRef]
5. Milliron, B.; Bruneau, M.; Obeid, E.; Gross, L.; Bealin, L.; Smaltz, C.; Giri, V.N. Diet assessment among men undergoing genetic
counseling and genetic testing for inherited prostate cancer: Exploring a teachable moment to support diet intervention. Prostate
2019, 79, 778–783. [CrossRef]
6. Hager, M.H.; Solomon, K.R.; Freeman, M.R. The role of cholesterol in prostate cancer. Curr. Opin. Clin. Nutr. Metab. Care. 2006, 9,
379–385. [CrossRef]
7. Moon, H.; Ruelcke, J.; Choi, E.; Sharpe, L.; Nassar, Z.; Bielefeldt-Ohmann, H.; Parat, M.-O.; Shah, A.; Francois, M.; Inder, K.L.; et al.
Diet-Induced Hypercholesterolemia Promotes Androgen-Independent Prostate Cancer Metastasis via IQGAP1 and Caveolin-1.
Oncotarget 2015, 6, 7438–7453. [CrossRef]
8. Whittemore, A.S.; Kolonel, L.N.; Wu, A.H.; John, E.M.; Gallagher, R.P.; Howe, G.R.; Burch, J.D.; Hankin, J.; Dreon, D.M.; West,
D.W.; et al. Prostate Cancer in Relation to Diet, Physical Activity, and Body Size in Blacks, Whites, and Asians in the United States
and Canada. J. Natl. Cancer Inst. 1995, 87, 652–661. [CrossRef]
9. Buszewska-Forajta, M.; Pomastowski, P.; Monedeiro, F.; Walczak-Skierska, J.; Markuszewski, M.; Matuszewski, M.; Markuszewski,
M.J.; Buszewski, B. Lipidomics as a Diagnostic Tool for Prostate Cancer. Cancers 2021, 13, 2000. [CrossRef] [PubMed]
谢谢各位老师！ |
|
发表于 2021-10-4 13:35:57
发表于 2021-10-5 13:37:25
